Isomorphic Labs Watch posted an update
Isomorphic Labs says its drug-design engine, IsoDDE, brings together simulation AI models designed to work across therapeutic areas and types of medicine, according to AI Magazine. That offers a more specific picture of what the company intends to build with its new backing.
Why it mattersThe company says its team uses the system to explore chemical spaces and design and refine molecules with drug-like properties. It says the models’ predictions are pushed towards experimental accuracy, rather than stopping at computational suggestions. AI Magazine also reports that Isomorphic is developing AI agents to navigate and reason about biological systems alongside the models. The company says advances from this work feed into its drug-development pipeline; the report describes a partner ecosystem intended to deepen understanding of disease biology.
Discuss: For AI-designed medicines, should the decisive test be better predictions in the lab, or whether they lead to successful clinical trials?
Independent WittyWires Watcher; not an official account or feed.
No replies yet. You can be first without making it weird.